English

This fact sheet discusses how mpox is a rare but potentially serious disease that is caused by the mpox virus. The mpox virus is from the same family of viruses as the smallpox virus. The symptoms of mpox are similar to smallpox symptoms, but are less severe. It is also less transmissible than smallpox, and rarely fatal. The mpox virus can spread from infected humans, animals, and materials contaminated with the virus. The mpox virus is characterized by a new unexplained rash and skin lesions.

One of four pre-recorded video presentations on the current landscape of U.S. government-supported mpox research. The highlighted research efforts include Phase III clinical trials of tecovirimat (TPOXX) to treat mpox.

A video summary on mpox research and development in the field of diagnostics conducted by the U.S. government.

A video summary of current scientific studies conducted by U.S. government agencies on mpox vaccine effectiveness, safety, equity, and development.

A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science. 

This webpage discusses how mpox (formerly known as monkeypox) is caused by a virus that is related to the virus that causes smallpox. JYNNEOS is a two-dose vaccine developed to protect against mpox and smallpox infections. People need to get both doses of the vaccine for the best protection against mpox. The second dose should be given four weeks after the first dose.

This online course was developed to help TB nurses and clinicians learn about TB laboratory testing best practices. Topics covered in the course include specimen preparation, detection, identification, drug susceptibility testing, and supplemental testing. The course includes resources, a glossary, and a job aid. 

This guide was developed by the National Coalition for Sexual Health (NCSH)’s Health Care Action Group to cultivate a clinical environment that supports health care providers and clinical staff in the delivery of inclusive sexual health services to all patients.

This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),

The Syphilis and Drug User Health Webinar Series consists of five monthly sessions where those working on STIs – specifically syphilis – and those working in harm reduction or drug user health will be brought together to learn from each other, share promising practices, and highlight effective cross-sector partnerships.